Pharmacognosy Magazine

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 13  |  Issue : 51  |  Page : 549--554

Antiurolithiatic potential of neeri against calcium-oxalate stones by crystallization inhibition, free radicals scavenging, and NRK-52E cell protection from oxalate injury


Parveen Kumar Goyal1, Santosh Kumar Verma2, Anil Kumar Sharma3 
1 Research Scholar, I.K.G. Punjab Technical University, Kapurthala, Punjab; Department of Pharmacology, Hindu College of Pharmacy, Sonepat, Haryana, India
2 Department of Pharmacology, Motherhood University, Roorkee, Uttrakhand, India
3 Department of Pharmacognosy, CT Institute of Pharmaceutical Sciences, Jalandhar, Punjab, India

Correspondence Address:
Anil Kumar Sharma
E-91, Naraina Vihar, New Delhi- 110 028
India

Background: Neeri is a well-established polyherbal formulation prescribed for renal stones by the physicians but has not been experimentally evaluated for its antiurolithiatic potential using cell-lines. Objective: This study is aimed to scientifically substantiate the antiurolithiatic effect of Neeri extract (NRE) through calcium oxalate (CaOx) crystallization inhibition, scavenging of free radicals, and protection of renal tubular epithelial NRK-52E cells from oxalate-induced injury. Materials and Methods: The crystallization inhibition was studied by turbidimetric assay while the free radical scavenging potential was determined for superoxide and nitric oxide (NO) radicals. The cytoprotective effect against oxalate-induced injury was assessed by estimating lactate dehydrogenase (LDH) leakage and determining cell viability using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results: NRE significantly inhibited the CaOx crystallization in a concentration-dependent manner and also scavenged superoxide (IC50 302.88 μ g/ml) and NO (IC50 300.45 μ g/ml) free radicals. It did not show any significant cytotoxicity for NRK-52E cells till the highest dose (500 μ g/ml) and found to be safe. When NRK-52E cells, injured by exposing to oxalate crystals for 24 h, were treated with NRE, it appreciably prevented the cell injury in a dose-dependent manner. It significantly decreased the elevated LDH leakage toward normal range and improved renal cell viability (82.37% ± 0.87%), hence, prevented growth and retention of crystals. Conclusion: The experimental findings concluded that Neeri is a potent antiurolithiatic formulation that inhibited CaOx crystallization and prevented tubular retention of crystals by protecting the renal cells against oxalate-induced injury as well as reducing the oxidative stress by scavenging free radicals. Abbreviations used: Ac: Absorbance of control, At: Absorbance of test, ANOVA: Analysis of variance, CaOx: Calcium oxalate, DMEM: Dulbecco's Modified Eagle's Medium, DMSO: Dimethyl sulfoxide, EDTA: Ethylenediaminetetraacetic acid, FBS: Fetal bovine serum, INT: Iodonitrotetrazolium, LDH: Lactate dehydrogenase, M: Molar, ml: Milliliter, mM: Millimolar, MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, NAD: Nicotinamide adenine dinucleotide, NADPH: Nicotinamide adenine dinucleotide phosphate, NBT: Nitro blue tetrazolium, nm: Nanometer, NO: Nitric oxide, NRE: Neeri extract, PMS: Phenazine methosulfate, ROS: Reactive oxygen species, Sc: Slope of the graph of control, SEM: Standard error of mean, Si: Slope of the graph with inhibitor, U/I: International unit, μg: Microgram, μl: Microliter.


How to cite this article:
Goyal PK, Verma SK, Sharma AK. Antiurolithiatic potential of neeri against calcium-oxalate stones by crystallization inhibition, free radicals scavenging, and NRK-52E cell protection from oxalate injury.Phcog Mag 2017;13:549-554


How to cite this URL:
Goyal PK, Verma SK, Sharma AK. Antiurolithiatic potential of neeri against calcium-oxalate stones by crystallization inhibition, free radicals scavenging, and NRK-52E cell protection from oxalate injury. Phcog Mag [serial online] 2017 [cited 2022 Dec 8 ];13:549-554
Available from: http://www.phcog.com/article.asp?issn=0973-1296;year=2017;volume=13;issue=51;spage=549;epage=554;aulast=Goyal;type=0